Wall Street brokerages expect Msci Inc (NYSE:MSCI) to report earnings per share of $1.61 for the current quarter, according to Zacks. Three analysts have issued estimates for Msci’s earnings, with the highest EPS estimate coming in at $1.62 and the lowest estimate coming in at $1.59. Msci reported earnings per share of $1.31 in the same quarter last year, which would suggest a positive year over year growth rate of 22.9%. The company is scheduled to issue its next earnings report before the market opens on Thursday, January 30th.
On average, analysts expect that Msci will report full year earnings of $6.39 per share for the current financial year, with EPS estimates ranging from $6.36 to $6.42. For the next financial year, analysts expect that the firm will report earnings of $7.19 per share, with EPS estimates ranging from $6.86 to $7.35. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that cover Msci.
Msci (NYSE:MSCI) last released its quarterly earnings data on Thursday, October 31st. The technology company reported $1.68 EPS for the quarter, beating analysts’ consensus estimates of $1.59 by $0.09. The business had revenue of $394.25 million during the quarter, compared to the consensus estimate of $387.79 million. Msci had a negative return on equity of 243.52% and a net margin of 39.20%. The firm’s revenue was up 10.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.35 earnings per share.
Several equities research analysts have issued reports on MSCI shares. Buckingham Research lowered their price target on Msci from $222.00 to $218.00 and set a “neutral” rating for the company in a report on Friday, October 11th. Zacks Investment Research upgraded shares of Msci from a “hold” rating to a “buy” rating and set a $291.00 target price for the company in a report on Friday. BMO Capital Markets increased their target price on shares of Msci from $252.00 to $268.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. Barclays reiterated a “buy” rating and set a $290.00 target price on shares of Msci in a report on Wednesday, December 18th. Finally, UBS Group increased their target price on shares of Msci from $235.00 to $238.00 and gave the stock a “neutral” rating in a report on Wednesday, October 2nd. Six research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $246.11.
Shares of Msci stock traded up $0.77 during trading hours on Friday, hitting $278.06. The company’s stock had a trading volume of 2,917 shares, compared to its average volume of 430,945. Msci has a 12 month low of $158.51 and a 12 month high of $277.32. The stock has a 50 day moving average of $261.79 and a 200 day moving average of $240.42. The company has a market capitalization of $23.23 billion, a PE ratio of 52.00, a price-to-earnings-growth ratio of 3.73 and a beta of 1.13.
In other Msci news, COO Laurent Seyer sold 6,000 shares of the business’s stock in a transaction dated Wednesday, November 20th. The shares were sold at an average price of $256.16, for a total value of $1,536,960.00. Following the completion of the sale, the chief operating officer now directly owns 105,787 shares of the company’s stock, valued at approximately $27,098,397.92. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Benjamin F. Dupont sold 8,000 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $238.51, for a total transaction of $1,908,080.00. Following the completion of the sale, the director now directly owns 17,095 shares of the company’s stock, valued at $4,077,328.45. The disclosure for this sale can be found here. Insiders sold 53,873 shares of company stock valued at $13,567,148 over the last 90 days. 3.10% of the stock is currently owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the business. Man Group plc grew its position in Msci by 26.8% in the 2nd quarter. Man Group plc now owns 499,154 shares of the technology company’s stock worth $119,193,000 after purchasing an additional 105,428 shares during the period. Worldquant Millennium Advisors LLC lifted its holdings in Msci by 0.5% during the third quarter. Worldquant Millennium Advisors LLC now owns 48,959 shares of the technology company’s stock valued at $10,660,000 after purchasing an additional 248 shares in the last quarter. Tower Research Capital LLC TRC purchased a new position in Msci during the third quarter valued at $779,000. Thor Advisors LLC purchased a new position in Msci during the third quarter valued at $34,000. Finally, SG Americas Securities LLC lifted its holdings in Msci by 8.6% during the third quarter. SG Americas Securities LLC now owns 12,358 shares of the technology company’s stock valued at $2,691,000 after purchasing an additional 975 shares in the last quarter. 91.71% of the stock is owned by institutional investors.
Msci Company Profile
MSCI Inc, together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. The company operates through four segments: Index, Analytics, ESG, and Real Estate. The Index segment primarily provides equity indexes for use in various areas of the investment process, including index-linked product creation and performance benchmarking, as well as portfolio construction and rebalancing, and asset allocation.
Read More: Are sell-side analysts objective?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Msci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Msci and related companies with MarketBeat.com's FREE daily email newsletter.